Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11000522 Bromocriptine formulations

Patent 11000522 was granted and assigned to Veroscience on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Laura Jean Weston0

Anthony H. Cincotta0

Craig Michael Bowe0

Paul Clark Stearns0

Date of Patent

May 11, 2021

0

Patent Application Number

168784510

Date Filed

May 19, 2020

0

Patent Citations

US Patent 10688094 Bromocriptine formulations

0

US Patent 10307421 Bromocriptine formulations

Patent Citations Received

US Patent 11883399 Bromocriptine formulations

0

US Patent 11560375 Composition and method for treating metabolic disorders

US Patent 11607455 Method for inducing tumor regression

US Patent 11666567 Bromocriptine formulations

0

US Patent 11878974 Composition and method for treating metabolic disorders

0

US Patent 11510921 Bromocriptine formulations

Patent Primary Examiner

Benjamin J Packard

0

Patent abstract

The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11000522 Bromocriptine formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool